Through the PI3K/AKT/mTOR and MEK/ERK pathways and various STAT5 downstream signalling events, the MCL-1 protein level is increased while the expression of BAD and BIM is suppressed to inhibit AML cell apoptosis [62, 66]. Here, MCL1 is linked to acute myeloid leukemia.